D E Sutherland
Overview
Explore the profile of D E Sutherland including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
866
Citations
5680
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Williams S, Sutherland D, Frazier 2nd H, Schwartz A, Engel J
J Robot Surg
. 2016 Sep;
3(3):137.
PMID: 27638369
The aim of this study is to explore the use of pathologically confirmed capsular incision and denudation as a measure of adequacy of extirpation following robot-assisted laparoscopic prostatectomy (RALP). All...
2.
Beta Cell Replacement Therapy in the 1990's An Overview of Pancreatic and Islet Cell Transplantation
Levy M, Brayman K, Sutherland D
Surg Technol Int
. 2015 May;
2:157-64.
PMID: 25951557
The goal of pancreatic beta cell replacement therapy is to restore normoglycemia in insulinopenic Type I diabetics patients. Pancreas transplantation is now considered a therapeutic option for Type I diabetic...
3.
Chinnakotla S, Majumder K, Sutherland D
Minerva Chir
. 2015 Jan;
70(1):57-62.
PMID: 25584826
Pancreas transplants are now highly effective for patients with diabetes mellitus. Improvements in outcomes have primarily been due to significant reductions in technical failures and immunological graft loss. In this...
4.
Scott 3rd W, Matsumoto S, Tanaka T, Avgoustiniatos E, Graham M, Williams P, et al.
Transplant Proc
. 2008 Apr;
40(2):403-6.
PMID: 18374082
31P-NMR spectroscopy was utilized to investigate rat and porcine pancreatic ATP:P(i) ratios to assess the efficacy of existing protocols for cold preservation (CP) in maintaining organ quality. Following sacrifice, rat...
5.
Gruessner A, Sutherland D
Clin Transpl
. 2002 Sep;
:41-72.
PMID: 12211799
As of October 10, 2001, > 17,000 pancreas transplant had been reported to the IPTR, > 11,500 in the US and > 4,700 outside the US. An era analysis of...
6.
Matas A, Ramcharan T, Paraskevas S, Gillingham K, Dunn D, Gruessner R, et al.
Am J Transplant
. 2002 Jul;
1(3):278-83.
PMID: 12102262
Unlabelled: Steroids are associated with significant postoperative complications (hypertension, cosmetic changes, bone loss, hyperlipidemia, diabetes, and cataracts). Most develop early; in addition, late post-transplant steroid withdrawal in kidney transplant recipients...
7.
Shibata S, Kirchhof N, Matsumoto S, Sageshima J, Hiraoka K, Ansite J, et al.
Transplant Proc
. 2002 Jun;
34(4):1341-4.
PMID: 12072355
No abstract available.
8.
Bruce D, Sollinger H, Humar A, Sutherland D, Light J, Kaufman D, et al.
Transplantation
. 2001 Dec;
72(10):1637-43.
PMID: 11726823
We report an experience with 71 simultaneous kidney-pancreas transplant (SKPT) recipients receiving daclizumab induction in combination with tacrolimus (TAC), mycophenolate mofetil (MMF), and steroids. The mean follow-up time was 5.9+/-2.5...
9.
Matas A, Humar A, Kandaswamy R, Payne W, Gruessner R, Sutherland D
Clin Transplant
. 2001 Oct;
15(4):236-9.
PMID: 11683816
Given the constant flux in caseload and the number of personnel available in the OR, waiting for a final XM often prolongs organ preservation time (a room available at the...
10.
Paty B, Lanz K, Kendall D, Sutherland D, Robertson R
Transplantation
. 2001 Oct;
72(6):1103-7.
PMID: 11579308
Background: Pancreas transplantation has been shown to fully restore glucagon response and partially restore epinephrine response to hypoglycemia during the first few years after transplantation in patients with type 1...